Cough Remedies Market

Cough Remedies Market Highlights

The global cough remedies market is expected to cross a value of USD 40.6 billion by the end of 2032. The market was valued at USD 37.9 billion in 2023 and is expected to expand at a CAGR of 0.7% between 2024-2032.

• Over the mid-term, the rising awareness about health and wellness amongst individuals is the primary factor anticipated to drive the global cough remedies market.
• The stern regulations and safety awareness regarding cough remedies is a major factor to challenge the market growth.
• The North America cough remedies market is projected to dominate the global market.

Cough Remedies Market Outlook

The medications, treatments, or products used to alleviate symptoms associated with coughing are known as cough remedies. Cough remedies help to relief from cough symptoms by soothing irritation, reducing inflammation, and suppressing the cough reflex. These remedies can be of different types including oral medications, throat sprays, herbal teas, and inhalants.

Consumers around the globe are nowadays mounting their search for cold and cough symptoms due to the rising awareness about health and wellness. Our researchers have found that the global prevalence of chronic cough varies between 3% and 17% across geographical region. The desire for natural and herbal remedies has been high among individuals as they are becoming more conscious about the probable ill effects of traditional medicines. Reckitt Benckiser Group PLC, Johnson & Johnson Services, Inc., and GlaxoSmithKline plc. are some of the significant parties in the global market for cough remedies.

                           Get More Insights on This Report - Request Free Sample PDF

Cough Remedies Market Drivers – Analyst’s Observation

According to the analysts at KD Market Insights, some key growth drivers for the global cough remedies market are:

• Increasing Occurrence of Respiratory Diseases: The respiratory diseases such as cold, flu, bronchitis, and asthma are increasing nowadays, especially after COVID-19, which is contributing to the growth of the cough remedies market. Around the world cough or respiratory illness is common. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) related deaths recorded to be 3.23 million in 2019. Hence, such a factor is expected to create an endless demand for effective cough remedies to relieve from symptoms such as coughing congestion and throat irritation, and in turn, boost the market growth.
• Growing Adoption of Home Remedies for Minor Ailments: People worldwide are nowadays paying increased attention to self-care and home remedies for minor ailments, including cough and colds. Consumers are gradually favoring treatments at home for mild cough symptoms using over-the-counter cough remedies rather than seeking medical assistance. This drift is geared toward the availability of a wide range of cough remedies in pharmacies, supermarkets, and online platforms.

Which Probable Factors Could Hamper the Growing Cough Remedies Market Trend?

As per our KD Market Insights analysis, some of the challenges expected to limit the global market growth of cough remedies are:

• Stern Regulations and Safety Awareness Regarding Cough Remedies: Strict regulations including approval processes, labeling regulations, and restrictions on ingredient use are imposing challenges for manufacturers or the makers of cough remedy drugs. Moreover, awareness related to misuse or overuse of certain cough remedies specifically among children, pregnant women, and old people is expected to affect the growth of the market.
• Growing Contest Among Home Remedies and Natural Remedies: The easy accessibility of home remedies and natural remedies for the ailment of cough such as herbal teas, honey and steam inhalation are contesting with the commercially offered cough remedies. Many customers choose natural remedies due to safety, efficacy, and affordability which is expected to limit the needs for traditional cough remedies in the market.

How is the Global Cough Remedies Market Segmented?

Our experts at KD Market Insights have segmented the global cough remedies market as:

What are the Probable Factors Influencing the North America Cough Remedies Market Forecast?

The North America cough remedies market is majorly driven by the rush in healthcare expenses on respiratory diseases. Moreover, a swell in the elderly population and multidrug resistance among grown up person and children is projected to enhance the need for novel drugs. Consequently, the presence of a strong healthcare network, along with the easy accessibility to OTC drugs and the increasing emphasis on health consciousness and self-care practices, are also expected to contribute to the growth of the market in the coming years.

As per our analysts at KD Market Insights, the following five players lead the North America cough remedies market growth:

• CoughAway Pharmaceuticals
• BreatheEasy Solutions
• ColdCalm Corporation
• ClearThroat Innovations
• RespiraRelief Pharmaceuticals

Which Key Players Top the Global Cough Remedies Market Share?

As per our analysts at KD Market Insights, the competitive landscape of global cough remedies market facilitates our readers in identifying their closest competitors. The manufacturers who are associated with cough remedies market are raising their focus on expanding their presence, as well as their market share. The market has also been witnessing an upward movement in the number of collaborations between research institutions and key players, aimed at introducing advanced technologies and innovation of new products. Here is a list of the key players who top the global cough remedies market share:

• Reckitt Benckiser Group PLC
• Johnson & Johnson Services, Inc.
• GlaxoSmithKline plc.
• Novartis AG
• Bayer AG
• AstraZeneca plc.
• Sun Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Prestige Brands Holdings, Inc.
• Procter & Gamble Co.

What are the Recent Developments Observed in the Cough Remedies Market?

Over the years, the experts at KD Market Insights have been observing the recent developments associated with global cough remedies market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful key strategies including new product launches, mergers & acquisitions, and collaborations.

For instance, GSK plc. shared that it has signed an acquisition deal with Bellus Health to strengthen its clinical pipeline portfolio that includes syrups and other formulations.

Further, Merck announced that it has received a complete response letter (CRL) from the United States Food and Drug Administration (FDA) for its new drug application called gefapixant. Gefapixant is an investigation drug used for treating patients with refractory chronic cough (RCC) in adults.